There Is Clear Momentum For Celestica, Inc. (NYSE: CLS)

Celestica, Inc. (CLS) concluded trading on Thursday at a closing price of $36.12, with 4.31 million shares of worth about $155.74 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 72.99% during that period and on Thursday, February 01 price saw a gain of about 5.12%. Currently the company’s common shares owned by public are about 116.54M shares, out of which, 114.93M shares are available for trading.

According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 94 times over the past 12 months. They bought 22,150,221 shares in 56 of the transactions. In 38 selling transactions, insiders dumped 21,501,079 shares.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

However, the stock later moved at a day high price of 36.34, or with a gain of 5.12%. Stock saw a price change of 13.87% in past 5 days and over the past one month there was a price change of 27.77%. Year-to-date (YTD), CLS shares are showing a performance of 23.36% which increased to 170.97% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $10.50 but also hit the highest price of $35.23 during that period. The average intraday trading volume for Celestica, Inc. shares is 1.75 million. The stock is currently trading 20.26% above its 20-day simple moving average (SMA20), while that difference is up 25.25% for SMA50 and it goes to 69.98% higher than SMA200.

Celestica, Inc. (NYSE: CLS) currently have 116.54M outstanding shares and institutions hold larger chunk of about 76.54% of that.

The stock has a current market capitalization of $4.21B and its 3Y-monthly beta is at 2.17. PE ratio of stock for trailing 12 months is 17.71, while it has posted earnings per share of $2.04 in the same period. Its PEG reads 0.66 and has Quick Ratio of 0.75 while making debt-to-equity ratio of 0.44. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CLS, volatility over the week remained 4.96% while standing at 4.23% over the month.

Analysts are in expectations that Celestica, Inc. (CLS) stock would likely to be making an EPS of $CVS Health Corporation in the current quarter, while forecast for next quarter EPS is $73.92 and it is $Stocks for next year. For the current quarter EPS, analysts have given the company a lowest target $CleanSpark, Inc. which is $SELLAS Life Sciences Group, Inc at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of $Clorox Company (The) in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 18.22% while it is estimated to increase by 11.16% in next year. EPS is likely to grow at an annualized rate of 26.80% for next 5-years, compared to annual growth of 23.48% made by the stock over the past 5-years.

Most Popular

Related Posts